StockNews.com assumed coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research note issued to investors on Wednesday morning. The firm issued a sell rating on the medical research company’s stock.
OpGen Stock Performance
NASDAQ OPGN opened at $1.11 on Wednesday. OpGen has a fifty-two week low of $1.00 and a fifty-two week high of $9.90. The business has a 50 day moving average price of $1.65 and a two-hundred day moving average price of $2.17.
OpGen Company Profile
See Also
- Five stocks we like better than OpGen
- 3 Grocery Stocks That Are Proving They Are Still Essential
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- What is the S&P/TSX Index?
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- P/E Ratio Calculation: How to Assess Stocks
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.